State Of Tennessee, Treasury Department I Teos Therapeutics, Inc. Transaction History

State Of Tennessee, Treasury Department

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$12.93 - $18.05 $21,011 - $29,331	1,625 Added 11.2%	16,137 $213,000
Q1 2023 May 12, 2023	SELL	$13.02 - $22.62 $13,644 - $23,705	-1,048 Reduced 6.74%	14,512 $197,000
Q4 2022 Feb 15, 2023	BUY	$17.77 - $21.6 $26,086 - $31,708	1,468 Added 10.42%	15,560 $304,000
Q3 2022 Jan 26, 2023	SELL	$18.6 - $27.25 $1,339 - $1,962	-72 Reduced 0.51%	14,092 $269,000
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $13,206 - $27,974	797 Added 5.96%	14,164 $292,000
Q1 2022 May 11, 2022	BUY	$31.92 - $47.45 $426,674 - $634,264	13,367 New	13,367 $430,000

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.